Literature DB >> 12205270

Clinical profile of 30 infants with acute pulmonary hemorrhage in Cleveland.

Dorr G Dearborn1, Paul G Smith, Beverly B Dahms, Terrence M Allan, W G Sorenson, Eduardo Montana, Ruth A Etzel.   

Abstract

Between 1993 and 2000, 30 infants were hospitalized with acute pulmonary hemorrhage at Rainbow Babies and Children's Hospital in Cleveland. Most infants presented with severe pulmonary symptoms requiring intensive support, but a few infants had less severe hemorrhage. Three quarters of the patients required ventilator support and blood transfusions. Eleven patients had transitory hemoglobinuria. Five patients died, but infants who survived did well. There are currently no specific treatment modalities, although we have advised moving to a different home and avoiding environmental tobacco smoke. Subsequently, rebleeding from the lower respiratory tract has decreased from 5 of 7 infants to 1 in 21. On the basis of decreased subsequent fatal hemorrhage, high dose glucocorticoids seem to be of some value. Several patients revealed continued low-grade alveolar hemorrhage for months after their initial bleed, even after removal from their original home environments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12205270     DOI: 10.1542/peds.110.3.627

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  25 in total

1.  Pulmonary responses to Stachybotrys chartarum and its toxins: mouse strain affects clearance and macrophage cytotoxicity.

Authors:  Jamie H Rosenblum Lichtenstein; Ramon M Molina; Thomas C Donaghey; Chidozie J Amuzie; James J Pestka; Brent A Coull; Joseph D Brain
Journal:  Toxicol Sci       Date:  2010-04-12       Impact factor: 4.849

2.  Occurrence of Stachybotrys chartarum chemotype S in dried culinary herbs.

Authors:  Barbara Biermaier; Christoph Gottschalk; Karin Schwaiger; Manfred Gareis
Journal:  Mycotoxin Res       Date:  2014-10-28       Impact factor: 3.833

3.  Biomechanics of conidial dispersal in the toxic mold Stachybotrys chartarum.

Authors:  Kathryn Tucker; Jessica L Stolze; Aaron H Kennedy; Nicholas P Money
Journal:  Fungal Genet Biol       Date:  2006-12-24       Impact factor: 3.495

4.  Acute Idiopathic Pulmonary Haemorrhage in a 2 month old Infant: Case report and review of the literature.

Authors:  Salem Al-Tamemi; Hussein Al-Kindi
Journal:  Sultan Qaboos Univ Med J       Date:  2009-06-30

5.  Germination, viability and clearance of Stachybotrys chartarum in the lungs of infant rats.

Authors:  Iwona Yike; Stephen Vesper; Joseph F Tomashefski; Dorr G Dearborn
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

6.  Repeated Mouse Lung Exposures to Stachybotrys chartarum Shift Immune Response from Type 1 to Type 2.

Authors:  Jamie H Rosenblum Lichtenstein; Ramon M Molina; Thomas C Donaghey; Yi-Hsiang H Hsu; Joel A Mathews; David I Kasahara; Jin-Ah Park; André Bordini; John J Godleski; Bruce S Gillis; Joseph D Brain
Journal:  Am J Respir Cell Mol Biol       Date:  2016-10       Impact factor: 6.914

7.  The role of fungal proteinases in pathophysiology of Stachybotrys chartarum.

Authors:  Iwona Yike; Thomas Rand; Dorr G Dearborn
Journal:  Mycopathologia       Date:  2007-07-03       Impact factor: 2.574

8.  The Evolution of the Satratoxin and Atranone Gene Clusters of Stachybotrys chartarum.

Authors:  Sebastian Ulrich; Katharina Lang; Ludwig Niessen; Christiane Baschien; Robert Kosicki; Magdalena Twarużek; Reinhard K Straubinger; Frank Ebel
Journal:  J Fungi (Basel)       Date:  2022-03-24

9.  Long-term liposteroid therapy for idiopathic pulmonary hemosiderosis.

Authors:  Takehiko Doi; Shouichi Ohga; Masataka Ishimura; Hidetoshi Takada; Kanako Ishii; Kenji Ihara; Hideyuki Nagai; Toshiro Hara
Journal:  Eur J Pediatr       Date:  2013-06-29       Impact factor: 3.860

10.  Extracorporeal life support for a 5-week-old infant with idiopathic pulmonary hemosiderosis.

Authors:  Sherrill Gutierrez; Susanna Shaw; Shehlanoor Huseni; Shagun Sachdeva; John P Costello; Sonali Basu; Dilip S Nath; Darren Klugman
Journal:  Eur J Pediatr       Date:  2013-08-14       Impact factor: 3.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.